Thiébaut, Rodolphe <br/><br/>
Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.  [electronic resource] 

 -  AIDS (London, England)  11 2017 
 - 2355-2365 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0000000000001628  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Biomarkers--blood<br/>Female<br/>HIV Infections--mortality<br/>Humans<br/>Interleukin-1 Receptor-Like 1 Protein--blood<br/>Interleukin-6--blood<br/>Lipopolysaccharide Receptors--blood<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Prospective Studies<br/>Risk Assessment<br/>Serum--chemistry<br/>Survival Analysis